Deborah Knobelman - Chief Financial Officer, Head of Corporate Development at Senti Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer, Head of Corporate Development
Stock Symbol
SNTI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Deborah Knobelman since 9/17/2023

Holdings reported by Deborah Knobelman for Senti Biosciences, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 152K Feb 1, 2024 Direct Common Stock
Common Stock 131K Feb 1, 2024 Direct

Transactions reported by Deborah Knobelman for Senti Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.